BioVentrix Announces the 1st Revivent TC(TM) TransCatheter Ventricular Enhancement Procedure in Germany After Receiving CE-Mark Certification

SAN RAMON, Calif., and HAMBURG, Germany, Dec. 19, 2016 -- (Healthcare Sales & Marketing Network) -- BioVentrix, Inc. a pioneer of technologies and procedures for less invasive treatment of heart failure (HF), today announced the first closed-chest Reviven... Devices, Interventional, Cardiology BioVentrix, Revivent TC, TransCatheter, Ventricular Enhancement, heart failure
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news